유럽의 비침습성 환기 마스크 시장 예측(-2031년) - 지역별 분석(제품별, 용도별, 최종 사용자별)

The Europe non-invasive ventilation masks market was valued at US$ 574.58 million in 2023 and is expected to reach US$ 922.02 million by 2031; it is estimated to register a CAGR of 6.1% from 2023 to 2031.

Growing Inclination Towards Home Healthcare Drive Europe Cosmetic Preservatives Market

A shift from long-term facilities, inpatient rehabilitation, and skilled nursing facilities to home care settings results in a better, consistent, and timely interaction between patient and doctor owing to the cloud and mobility-driven medical devices. The COVID-19 outbreak triggered home healthcare's importance due to limited hospital bed capacity and a scarcity of skilled healthcare professionals. With the help of home healthcare, healthcare professionals can monitor patient's vitals remotely and avoid hospital admissions.

Moreover, patients with conditions such as COPD, sleep apnea, and other respiratory issues are increasingly expressing a preference for at-home management of their ailments. Patients can use NIV therapy in the comfort of their homes without having to make frequent visits to the hospital. Home healthcare providers are prescribing NIV masks more frequently as a component of all-encompassing respiratory care plans.

Therefore, due to the growing traction toward home healthcare and increasing demand for more advanced, affordable, and easily navigable devices at home, the market for Noninvasive ventilation masks is gaining noticeable traction.

Europe Cosmetic Preservatives Market Overview

The Europe noninvasive ventilation masks market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The regional market is driven due to the increasing prevalence of chronic respiratory diseases, including COPD, OSA, acute respiratory failure (ARF), the presence of prominent players such as Philips, Intersurgical, and Hamilton Medical in the Europe noninvasive ventilation masks market, and strategic developments made by NIV masks manufacturers. In June 2020, ReddyPort, a medical technology company, received CE Mark approval for ReddyPort Elbow, a solution that supports NIV success and allows clinicians to perform procedures through the ventilation mask. This product approval allows the company to commercialize it across the European Union and other CE Mark geographies, including Romania, Spain, France, and Austria.

Europe Cosmetic Preservatives Market Revenue and Forecast to 2031 (US$ Million)

Europe Cosmetic Preservatives Market Segmentation

The Europe non-invasive ventilation masks market is categorized into product, application, end user, and country.

By product, the Europe non-invasive ventilation masks market is bifurcated into noninvasive ventilation disposable mask and noninvasive ventilation reusable mask. The noninvasive ventilation disposable mask segment held a larger share of the Europe non-invasive ventilation masks market share in 2023.

In terms of application, the Europe non-invasive ventilation masks market is segmented into sleep apnea, chronic obstructive pulmonary disease, pneumonia, and others. The sleep apnea segment held the largest share of the Europe non-invasive ventilation masks market share in 2023.

Based on end user, the Europe non-invasive ventilation masks market is segmented into hospitals and clinics, home care, and others. The hospitals and clinics segment held the largest share of the Europe non-invasive ventilation masks market share in 2023.

Based on country, the Europe non-invasive ventilation masks market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany segment held the largest share of Europe non-invasive ventilation masks market in 2023.

Air Liquide Medical Systems; Armstrong Medical Ltd; Besmed Health Business Corp; BMC Medical Co Ltd; DeVilbiss Healthcare LLC; Dimar S.P.A.; Dragerwerk AG & Co KGaA; Fisher & Paykel Healthcare Corp Ltd; Hamilton Medical AG; Hangzhou Formed Medical Devices Co., Ltd; Intersurgical Ltd; Koninklijke Philips NV; Medline Industries LP; ResMed Inc; Sleepnet Corporation; SunMed Group Holdings LLC ( AirLife); and SURU INTERNATIONAL PVT. LTD. are some of the leading companies operating in the Europe non-invasive ventilation masks market.

Table Of Contents

1. Introduction

• 1.1 Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Secondary Research
• 3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Non-Invasive Ventilation Masks Market Landscape

• 4.1 PEST Analysis

5. Europe Non-Invasive Ventilation Masks Market - Key Market Dynamics

• 5.1 Europe Non-Invasive Ventilation Masks Market - Key Market Dynamics
• 5.2 Market Drivers
  • 5.2.1 Increasing Prevalence of Respiratory Diseases
  • 5.2.2 Growing Inclination Towards Home Healthcare
• 5.3 Market Restraints
  • 5.3.1 Side Effects Associated with NIV Masks
• 5.4 Market Opportunities
  • 5.4.1 Increasing Adoption of NIV Masks
• 5.5 Future Trends
  • 5.5.1 Rising Technological Advancements
• 5.6 Impact of Drivers and Restraints:

6. Europe Non-Invasive Ventilation Masks Market - Analysis

• 6.1 Europe Non-Invasive Ventilation Masks Market Revenue (US$ Million), 2021-2031
• 6.2 Europe Non-Invasive Ventilation Masks Market Forecast Analysis

7. Europe Non-Invasive Ventilation Masks Market Analysis - by Product

• 7.1 Non-Invasive Ventilation Disposable Mask
  • 7.1.1 Overview
  • 7.1.2 Non-Invasive Ventilation Disposable Mask: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 7.2 Non-Invasive Ventilation Reusable Mask
  • 7.2.1 Overview
  • 7.2.2 Non-Invasive Ventilation Reusable Mask: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Non-Invasive Ventilation Masks Market Analysis - by Application

• 8.1 Sleep Apnea
  • 8.1.1 Overview
  • 8.1.2 Sleep Apnea: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 8.2 Chronic Obstructive Pulmonary Disease
  • 8.2.1 Overview
  • 8.2.2 Chronic Obstructive Pulmonary Disease: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 8.3 Pneumonia
  • 8.3.1 Overview
  • 8.3.2 Pneumonia: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 8.4 Others
  • 8.4.1 Overview
  • 8.4.2 Others: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Non-Invasive Ventilation Masks Market Analysis - by End User

• 9.1 Hospitals and Clinics
  • 9.1.1 Overview
  • 9.1.2 Hospitals and Clinics: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 9.2 Home Care
  • 9.2.1 Overview
  • 9.2.2 Home Care: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 9.3 Others
  • 9.3.1 Overview
  • 9.3.2 Others: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Non-Invasive Ventilation Masks Market - Country Analysis

• 10.1 Europe
  • 10.1.1 Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
    • 10.1.1.1 Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast Analysis - by Country
    • 10.1.1.2 United Kingdom: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.2.1 United Kingdom: Europe Non-Invasive Ventilation Masks Market Share - by Product
      • 10.1.1.2.2 United Kingdom: Europe Non-Invasive Ventilation Masks Market Share - by Application
      • 10.1.1.2.3 United Kingdom: Europe Non-Invasive Ventilation Masks Market Share - by End User
    • 10.1.1.3 Germany: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.3.1 Germany: Europe Non-Invasive Ventilation Masks Market Share - by Product
      • 10.1.1.3.2 Germany: Europe Non-Invasive Ventilation Masks Market Share - by Application
      • 10.1.1.3.3 Germany: Europe Non-Invasive Ventilation Masks Market Share - by End User
    • 10.1.1.4 France: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.4.1 France: Europe Non-Invasive Ventilation Masks Market Share - by Product
      • 10.1.1.4.2 France: Europe Non-Invasive Ventilation Masks Market Share - by Application
      • 10.1.1.4.3 France: Europe Non-Invasive Ventilation Masks Market Share - by End User
    • 10.1.1.5 Italy: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.5.1 Italy: Europe Non-Invasive Ventilation Masks Market Share - by Product
      • 10.1.1.5.2 Italy: Europe Non-Invasive Ventilation Masks Market Share - by Application
      • 10.1.1.5.3 Italy: Europe Non-Invasive Ventilation Masks Market Share - by End User
    • 10.1.1.6 Spain: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.6.1 Spain: Europe Non-Invasive Ventilation Masks Market Share - by Product
      • 10.1.1.6.2 Spain: Europe Non-Invasive Ventilation Masks Market Share - by Application
      • 10.1.1.6.3 Spain: Europe Non-Invasive Ventilation Masks Market Share - by End User
    • 10.1.1.7 Rest of Europe: Europe Non-Invasive Ventilation Masks Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.7.1 Rest of Europe: Europe Non-Invasive Ventilation Masks Market Share - by Product
      • 10.1.1.7.2 Rest of Europe: Europe Non-Invasive Ventilation Masks Market Share - by Application
      • 10.1.1.7.3 Rest of Europe: Europe Non-Invasive Ventilation Masks Market Share - by End User

11. Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in Noninvasive Ventilation Mask Market
• 11.3 Organic Growth Strategies
  • 11.3.1 Overview
• 11.4 Inorganic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Hamilton Medical AG
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 ResMed Inc
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Fisher & Paykel Healthcare Corp Ltd
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Air Liquide Medical Systems
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Dragerwerk AG & Co KGaA
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Intersurgical Ltd
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 BMC Medical Co Ltd
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 DeVilbiss Healthcare LLC
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 Armstrong Medical Ltd
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
• 12.10 Koninklijke Philips NV
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments
• 12.11 Besmed Health Business Corp
  • 12.11.1 Key Facts
  • 12.11.2 Business Description
  • 12.11.3 Products and Services
  • 12.11.4 Financial Overview
  • 12.11.5 SWOT Analysis
  • 12.11.6 Key Developments
• 12.12 Sleepnet Corporation.
  • 12.12.1 Key Facts
  • 12.12.2 Business Description
  • 12.12.3 Products and Services
  • 12.12.4 Financial Overview
  • 12.12.5 SWOT Analysis
  • 12.12.6 Key Developments
• 12.13 SunMed Group Holdings LLC ( AirLife)
  • 12.13.1 Key Facts
  • 12.13.2 Business Description
  • 12.13.3 Products and Services
  • 12.13.4 Financial Overview
  • 12.13.5 SWOT Analysis
  • 12.13.6 Key Developments
• 12.14 Dimar S.P.A.
  • 12.14.1 Key Facts
  • 12.14.2 Business Description
  • 12.14.3 Products and Services
  • 12.14.4 Financial Overview
  • 12.14.5 SWOT Analysis
  • 12.14.6 Key Developments
• 12.15 Hangzhou Formed Medical Devices Co., Ltd
  • 12.15.1 Key Facts
  • 12.15.2 Business Description
  • 12.15.3 Products and Services
  • 12.15.4 Financial Overview
  • 12.15.5 SWOT Analysis
  • 12.15.6 Key Developments
• 12.16 SURU INTERNATIONAL PVT. LTD.
  • 12.16.1 Key Facts
  • 12.16.2 Business Description
  • 12.16.3 Products and Services
  • 12.16.4 Financial Overview
  • 12.16.5 SWOT Analysis
  • 12.16.6 Key Developments
• 12.17 Medline Industries LP
  • 12.17.1 Key Facts
  • 12.17.2 Business Description
  • 12.17.3 Products and Services
  • 12.17.4 Financial Overview
  • 12.17.5 SWOT Analysis
  • 12.17.6 Key Developments

13. Appendix

• 13.1 About Us
• 13.2 List of Abbreviations